Neurocrine Biosciences Inc (NBIX)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

$145.21

Buy

$154.93

arrow-up$1.26 (+0.82%)

Prices updated at 15 Dec 2025, 13:57 EST

Prices minimum 15 mins delay

Prices in USD

Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.

NASDAQ

-0.59%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$155.55 - $151.12
	$160.18 - $84.23
	-
	15,360.66m
	36.77
	-
	518
	5.11
	1,158,798.14
	0.61
	99.40m
	US64125C1099
	4.19
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.